Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.

about

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

P2860

Q52642515-48F48D82-DC91-4BE8-B4A5-F879E9D89A3D

P2860

Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q46310024

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@en

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@nl

type

Item

label

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@en

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@nl

prefLabel

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@en

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@nl

P1476

Concomitant chemoradiotherapy ...... anal squamous cell carcinoma.

@en

P2093

Hanan Ahmed Wahba

http://www.w3.org/2001/XMLSchema#string

Hend Ahmed El-Hadaad

http://www.w3.org/2001/XMLSchema#string

Sameh Roshdy

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.

Twenty-five-year experience with radical chemoradiation for anal cancer.

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]

P2888

s12029-015-9707-2

P304

156-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12029-015-9707-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25810165

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.

about

P2860

P2860

Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921